China NMPA Whitening & Spot-Removing Cosmetics Registration

1. Physical-Covering Whitening Products May Qualify for a Toxicological Test-Report Exemption

For spot-removing and whitening products whose efficacy is achieved solely through physical coverage, specified product toxicological test reports may no longer need to be submitted where the applicable conditions are met.

This does not mean that such products are exempt from safety requirements.

The product must still meet the applicable safety-assessment requirements, and companies should verify whether all conditions for the exemption are satisfied before relying on it.

Products achieving whitening through biological or chemical mechanisms should not assume that the same exemption applies.

2. Certain Data May Be Shared Across Similar-Formula Product Families

For qualifying products under the same registrant and brand with similar formulation systems, certain safety-related or efficacy evaluation data may be shared where the relevant similarity criteria are fulfilled.

However:

• safety-data sharing and efficacy-data sharing are not governed by identical criteria;

• scientific justification remains necessary; and

• a product-specific safety assessment is still required.

This may be particularly relevant to companies planning a series of whitening, brightening or pigmentation-care products with closely related formulas.

3. Ingredient Safety Information Moves Toward Record Retention

Under the 2026 optimization measures, the way ingredient safety information is managed during registration and filing has been simplified.

Supporting ingredient safety documentation still needs to be properly retained and remain available for regulatory inspection.

For whitening cosmetics, this does not reduce the need to verify the safety, quality and regulatory suitability of functional ingredients.

4. China-First Global Launches May Benefit from Simplified Overseas Documentation

Eligible new international cosmetic products launched first in China, or simultaneously in China and other markets, may benefit from simplified documentation requirements relating to overseas marketing status.

This may be particularly useful for global brands planning China as part of an initial international launch rather than treating China as a secondary market.

5. Whitening Claims Remain a High-Attention Efficacy Category

Whitening and spot-removing claims continue to require particular attention to efficacy substantiation.

Companies should not assume that broader simplifications applicable to ordinary cosmetic efficacy claims automatically extend to whitening claims.

Before finalizing the China claim strategy, companies should review the applicable efficacy claim evaluationrequirements.

6. New Whitening Functional Ingredients Remain a Higher-Risk Category

If the finished product contains an ingredient that is new to cosmetic use in China and is intended to provide a freckle-removing or whitening function, the ingredient may need to complete new cosmetic ingredient registration before it can be used in the finished cosmetic product.

See REACH24H’s China New Cosmetic Ingredient Registration & Filing service for more information.

Companies should therefore assess the regulatory status of whitening functional ingredients before finalizing the finished-product registration strategy.

Step 1 — Product Classification and Registration Strategy

REACH24H first assesses:

• product function;

• intended claims;

• mechanism of action;

• formula;

• active or functional ingredients;

• product positioning; and

• existing overseas evidence.

The objective is to determine whether the product is:

• a freckle-removing and whitening special cosmetic;

• another type of special cosmetic;

• a general cosmetic with non-whitening brightening positioning; or

• subject to another regulatory pathway requiring further assessment.

Step 2 — Formula, Ingredient and Claim Pre-Review

The formula should be assessed for:

• ingredient regulatory status;

• restrictions and limits;

• whitening functional ingredients;

• ingredient safety information;

• new cosmetic ingredient status;

• quality specifications; and

• consistency between formula and intended claims.

At this stage, overseas claim wording should also be reviewed against the China regulatory classification.

Step 3 — Testing, Safety Assessment and Efficacy Strategy

Depending on the product and applicable requirements, the project may involve:

• microbiological testing;

• physicochemical testing;

• toxicological testing;

• human safety evaluation;

• efficacy evaluation; and

• preparation of the cosmetic safety assessment.

Whitening products require particular attention to efficacy substantiation.

The testing strategy, endpoints, product positioning and claim wording should therefore be aligned from the beginning.

The sequence of testing is also important. If preliminary testing identifies a compliance problem, proceeding directly to later-stage human testing can result in unusable data, retesting and project delay.

Step 4 — Registration Dossier Preparation and Submission

The registration dossier should establish a consistent evidence chain covering:

The dossier is submitted through the NMPA cosmetics registration and filing information platform.

Formal acceptance is followed by substantive technical review.

Step 5 — NMPA Technical Review and Supplementary Response

NMPA technical evaluation focuses on whether the submitted materials adequately demonstrate:

• product safety;

• formula rationality;

• quality control;

• efficacy substantiation;

• label compliance; and

• overall consistency of the registration dossier.

The statutory technical review period is generally 90 working days under the relevant NMPA registration provisions.

If deficiencies are identified, supplementary materials may be requested.

Additional testing or substantial dossier revisions can significantly extend the overall project timeline.

Step 6 — Approval and Post-Registration Compliance

After successful completion of technical review and regulatory approval, a special cosmetics registration certificate is issued.

The certificate is generally valid for five years.

Companies must subsequently manage lifecycle compliance issues such as:

• renewal;

• formula or product changes;

• manufacturer changes;

• Domestic Responsible Person changes;

• label updates;

• safety documentation;

• efficacy documentation; and

• post-market compliance obligations.

Get Your Whitening Cosmetic Assessed Before NMPA Submission

Not sure whether your “brightening,” “dark spot,” “tone-evening” or “pigmentation-care” product will be treated as a whitening special cosmetic in China?

Send REACH24H your:    product name, proposed China claims, formula or ingredient list, product origin, and planned launch date.

Our regulatory team can help assess:    product classification, NMPA registration pathway, formula risks, new ingredient status, testing requirements, potential 2026 exemptions, cosmetic safety assessment gaps, efficacy evidence, Chinese label risks, expected timeline, and project scope.